chr10-79611881-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005411.5(SFTPA1):āc.56T>Cā(p.Val19Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0867 in 1,431,716 control chromosomes in the GnomAD database, including 6,584 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005411.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPA1 | NM_005411.5 | c.56T>C | p.Val19Ala | missense_variant | 3/6 | ENST00000398636.8 | NP_005402.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPA1 | ENST00000398636.8 | c.56T>C | p.Val19Ala | missense_variant | 3/6 | 1 | NM_005411.5 | ENSP00000381633 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0883 AC: 10823AN: 122556Hom.: 571 Cov.: 32
GnomAD3 exomes AF: 0.0779 AC: 18458AN: 237012Hom.: 1906 AF XY: 0.0782 AC XY: 10002AN XY: 127874
GnomAD4 exome AF: 0.0866 AC: 113321AN: 1309066Hom.: 6006 Cov.: 121 AF XY: 0.0892 AC XY: 58301AN XY: 653952
GnomAD4 genome AF: 0.0884 AC: 10846AN: 122650Hom.: 578 Cov.: 32 AF XY: 0.0932 AC XY: 5576AN XY: 59842
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 30, 2015 | This is a homologous region and while the NGS call looks real we do not have a S anger primer pair where both primers are unique. The origin of this variant can not be unambiguously assigned and therefore it is excluded from patient reports. LMM is in the process of exuding repetitive regions where Sanger confirmation is not possible from tests (pending). p.Val34Ala in exon 3 of SFTPA1: This var iant was detected at high frequency in large cohorts sequenced by the ExAC conso rtium (http://exac.broadinstitute.org/). While the frequencies are high enough to rule out a pathogneic role the data did not pass quality filters. Other data supporting a benign role include to a lack of conservation across species, inclu ding mammals. Of note, the gorilla, orangutan, gibbon, rhesus, crab eating macaq ue, baboon, and green monkey have an alanine (Ala) at this position. In additio n, computational prediction tools do not suggest a high likelihood of impact to the protein. - |
See cases Benign:1
Likely benign, no assertion criteria provided | case-control | Department of Pediatrics, Penn State Hershey College of Medicine | - | - - |
SFTPA1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 22, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at